WO2021129617A3 - 一种用于预防、缓解或治疗皮肤过敏的外用组合物及其用途 - Google Patents

一种用于预防、缓解或治疗皮肤过敏的外用组合物及其用途 Download PDF

Info

Publication number
WO2021129617A3
WO2021129617A3 PCT/CN2020/138345 CN2020138345W WO2021129617A3 WO 2021129617 A3 WO2021129617 A3 WO 2021129617A3 CN 2020138345 W CN2020138345 W CN 2020138345W WO 2021129617 A3 WO2021129617 A3 WO 2021129617A3
Authority
WO
WIPO (PCT)
Prior art keywords
alleviating
treating skin
composition
topical composition
preventing
Prior art date
Application number
PCT/CN2020/138345
Other languages
English (en)
French (fr)
Other versions
WO2021129617A2 (zh
Inventor
王冠凤
石艳丽
董艳美
钱晓路
陈晨
刘玉敏
周雪
李晓天
郭学平
Original Assignee
华熙生物科技股份有限公司
山东华熙海御生物医药有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 华熙生物科技股份有限公司, 山东华熙海御生物医药有限公司 filed Critical 华熙生物科技股份有限公司
Publication of WO2021129617A2 publication Critical patent/WO2021129617A2/zh
Publication of WO2021129617A3 publication Critical patent/WO2021129617A3/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18

Abstract

一种安全环保、无副作用、无刺激、能有效预防、缓解或治疗皮肤过敏、抗炎、抗菌、抗刺激的外用组合物。该组合物包含四氢嘧啶或其衍生物、透明质酸或其衍生物、生物表面活性剂和ε-聚赖氨酸作为中心组合物，并任选包含一种或多种维生素，以及任选包含一种或多种天然植物成分。该组合物以化妆品形式、医疗器械形式、药品形式、或者以前述产品的添加物的形式提供。
PCT/CN2020/138345 2019-12-26 2020-12-22 一种用于预防、缓解或治疗皮肤过敏的外用组合物及其用途 WO2021129617A2 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911361962.9 2019-12-26
CN201911361962.9A CN110974830A (zh) 2019-12-26 2019-12-26 一种用于预防、缓解或治疗皮肤过敏的外用组合物及其用途

Publications (2)

Publication Number Publication Date
WO2021129617A2 WO2021129617A2 (zh) 2021-07-01
WO2021129617A3 true WO2021129617A3 (zh) 2021-10-07

Family

ID=70076934

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/138345 WO2021129617A2 (zh) 2019-12-26 2020-12-22 一种用于预防、缓解或治疗皮肤过敏的外用组合物及其用途

Country Status (2)

Country Link
CN (1) CN110974830A (zh)
WO (1) WO2021129617A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110974830A (zh) * 2019-12-26 2020-04-10 华熙生物科技股份有限公司 一种用于预防、缓解或治疗皮肤过敏的外用组合物及其用途
CN111714403B (zh) * 2020-06-02 2023-02-03 华熙生物科技股份有限公司 四氢嘧啶类物质的新应用及含四氢嘧啶类物质的清凉降温制剂
CN111840307B (zh) * 2020-08-18 2023-09-12 华熙生物科技股份有限公司 一种具有镇痛止痒和去湿疹功效的组合物
CN112870455B (zh) * 2021-02-05 2022-05-24 华熙生物科技股份有限公司 一种含透明质酸的凝胶制剂、制法及其在内窥镜检查中的应用
CN114533582B (zh) * 2022-02-25 2023-05-09 北京协和生物工程研究所有限公司 一种包含多种渗透压保护剂的眼周用组合物
CN115414262B (zh) * 2022-07-19 2023-09-22 江苏诺兴生物科技有限公司 一种ε-聚赖氨酸Pickering乳液及其制备方法和用途
CN116059303B (zh) * 2023-03-03 2023-06-13 广东青云山药业有限公司 一种复合骨碎补提取物及其制备工艺

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101036625A (zh) * 2006-03-13 2007-09-19 马小玲 甘菊褪红化妆品及其生产工艺
CN105769605A (zh) * 2016-04-25 2016-07-20 武文博 含人体活性透明质酸或人体活性透明质酸盐的化妆品
CN105796474A (zh) * 2016-05-10 2016-07-27 齐鲁工业大学 一种固体多功能面膜组合物及制备面膜的方法
CN105816907A (zh) * 2016-04-19 2016-08-03 上海昌颌医药科技有限公司 一种医用凝胶及其用于制备凝胶湿敷贴的制备方法
CN108685759A (zh) * 2018-07-11 2018-10-23 华熙福瑞达生物医药有限公司 一种透明质酸类物质和四氢嘧啶类物质的组合物
US20190099441A1 (en) * 2016-03-07 2019-04-04 Ursapharm Arzneimittel Gmbh Ophthalmological composition
CN110151594A (zh) * 2019-06-20 2019-08-23 华熙生物科技股份有限公司 一种含依克多因和透明质酸的口腔组合物及其应用
CN110974830A (zh) * 2019-12-26 2020-04-10 华熙生物科技股份有限公司 一种用于预防、缓解或治疗皮肤过敏的外用组合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109330911B (zh) * 2018-11-20 2021-07-23 华熙生物科技股份有限公司 一种含复合维生素和透明质酸盐的组合物及其应用
CN109363991A (zh) * 2018-11-28 2019-02-22 澳宝化妆品（惠州）有限公司 一种含抗过敏植物提取物的护肤组合物

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101036625A (zh) * 2006-03-13 2007-09-19 马小玲 甘菊褪红化妆品及其生产工艺
US20190099441A1 (en) * 2016-03-07 2019-04-04 Ursapharm Arzneimittel Gmbh Ophthalmological composition
CN105816907A (zh) * 2016-04-19 2016-08-03 上海昌颌医药科技有限公司 一种医用凝胶及其用于制备凝胶湿敷贴的制备方法
CN105769605A (zh) * 2016-04-25 2016-07-20 武文博 含人体活性透明质酸或人体活性透明质酸盐的化妆品
CN105796474A (zh) * 2016-05-10 2016-07-27 齐鲁工业大学 一种固体多功能面膜组合物及制备面膜的方法
CN108685759A (zh) * 2018-07-11 2018-10-23 华熙福瑞达生物医药有限公司 一种透明质酸类物质和四氢嘧啶类物质的组合物
CN110151594A (zh) * 2019-06-20 2019-08-23 华熙生物科技股份有限公司 一种含依克多因和透明质酸的口腔组合物及其应用
CN110974830A (zh) * 2019-12-26 2020-04-10 华熙生物科技股份有限公司 一种用于预防、缓解或治疗皮肤过敏的外用组合物及其用途

Also Published As

Publication number Publication date
WO2021129617A2 (zh) 2021-07-01
CN110974830A (zh) 2020-04-10

Similar Documents

Publication Publication Date Title
WO2021129617A3 (zh) 一种用于预防、缓解或治疗皮肤过敏的外用组合物及其用途
EP4230623A3 (en) Pyridine compounds as allosteric shp2 inhibitors
WO2018154145A3 (en) Retinol replacement in skin treatment
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
MX2020013064A (es) Lactobacillus plantarum para el cuidado de la piel.
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
Raharivelomanana et al. Tamanu oil and skin active properties: from traditional to modern cosmetic uses
BR112015005339A8 (pt) uso de óleo de semente de fruta milagrosa como um ingrediente ativo
FR3024037B1 (fr) Ingredient actif cosmetique ou dermatologique comprenant un melange d'acides dicarboxyliques gras insatures, compositions le comprenant et utilisations cosmetiques ou dermatologiques
TN2016000237A1 (en) Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses.
CA2780025C (en) Dermatological compositions comprising a fat or oil of an essential fatty acid triglyceride
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
PH12019502874A1 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
WO2014023895A3 (fr) Inhibition de l'adhesion de micro-organismes pathogenes par un sucrose stearate et/ou de sorbitan dans le traitement cosmetique de l'atopie cutanee
AR108437A1 (es) Agente externo cutáneo para mejorar las arrugas de la piel que comprende un extracto de germen de trigo fermentado
WO2012075093A3 (en) Topical formulations for administration of omega-3 fatty acids
WO2013190542A3 (en) Topical compositions for the treatment of chronic inflammatory skin disease
WO2018094023A3 (en) Cyclic dipeptides and wound healing
SG11201909144VA (en) Bacterial secretome for use in the treatment of skin lesions
AU2019211468B2 (en) Cannabinoid dosing regime for acne
WO2017142368A3 (ko) 알레르기성 또는 염증성 피부질환의 예방 또는 치료용 조성물
SG11201907398TA (en) Conjugate of salicylic acid and peptide
AU2017434946A8 (en) Pharmaceutical composition to be used for modification of scalp or skin, healing of wound or modification of hair
SG11201806628UA (en) New bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
EP3158989A3 (en) Cosmetic skin treatment composition

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20905682

Country of ref document: EP

Kind code of ref document: A2